FGFR4 and breast cancer: FGFR4 amplification occurred in 30 (1.6%) and 13 (1.3%) breast cancer patients in the METABRIC and TCGA datasets, respectively, and was observed in all subtypes, except normal (Fig. 5a, Additional file 4: Fig. S8a).